No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
517 |
4. Check minimum number of eventsNone |
517 |
5. Include endpointsNone |
517 |
6. Filter based on genotype QC (FinnGen only) |
517 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
LSIL lesion of the vagina
based on the number of shared cases.
Similar with more cases:
- All dysplastic lesions of the vagina
- Other noninflammatory disorders of vagina
- LSIL lesion of the cervix uteri, vagina or vulva
- All dysplastic lesions of the cervix uteri, vagina or vulva
- Noninflammatory disorders of female genital tract
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2429 | 2429 | - |
| Only index persons | 2363 | 2363 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.07 | - |
| Only index persons | 0.09 | 0.09 | - |
| Median age at first event (years) | |||
| Whole population | - | 50.78 | - |
| Only index persons | - | 50.56 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 517 | 517 | - |
| Unadjusted period prevalence (%) | 0.18 | 0.18 | - |
| Median age at first event (years) | 51.57 | 51.57 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 449
- Matched controls
- 4491
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N89.0
ICD-10 Finland
Mild vaginal dysplasia
+∞
323.0
449
*
ULA02
NOMESCO Finland
Kolposcopy
74.3
290.3
394
394
LEB00
NOMESCO Finland
Biopsy of vagina
118.6
246.3
255
49
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
37.2
229.0
351
394
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
16.0
143.7
289
455
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
246.4
126.9
125
7
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
17.0
126.1
225
250
N87.0
ICD-10 Finland
Mild cervical dysplasia
25.4
99.0
143
81
A63.0
ICD-10 Finland
Anogenital (venereal) warts
21.1
83.6
128
83
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
24.9
77.9
112
59
LDA10
NOMESCO Finland
Curettage of cervix uteri
12.2
67.1
131
147
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
12.4
65.4
126
137
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
162.7
55.3
57
*
N90.0
ICD-10 Finland
Mild vulvar dysplasia
143.4
48.9
51
*
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
+∞
31.6
30
*
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
27.3
29.3
40
16
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
71.0
29.3
33
5
N87.1
ICD-10 Finland
Moderate cervical dysplasia
10.0
26.9
55
62
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
14.3
25.3
43
33
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
15.7
23.9
39
27
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
8.2
19.9
45
60
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.5
19.0
233
1356
G01AA10
ATC
clindamycin; vaginal
2.7
17.7
150
703
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
165.5
15.6
16
*
D06BB10
ATC
imiquimod; topical
4.9
13.7
45
99
ZXC10
NOMESCO Finland
Use of laser
9.3
13.7
28
32
X86
ICPC
Abnormal cervix smear
19.0
13.5
20
11
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
23.4
13.0
18
8
A63.8
ICD-10 Finland
Other specified predominantly sexually transmitted diseases
123.0
11.5
12
*
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.9
10.3
282
2089
L04AX01
ATC
azathioprine; systemic
4.1
10.0
38
98
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
26.7
9.9
13
5
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.6
9.4
74
321
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
51.0
8.7
10
*
ZXC00
NOMESCO Finland
Use of diathermy
9.1
7.6
15
17
D06BB04
ATC
podophyllotoxin; topical
3.1
7.3
39
134
P01BA02
ATC
hydroxychloroquine; oral
2.4
6.9
57
255
LEB10
NOMESCO Finland
Excision of lesion of vagina
8.5
6.9
14
17
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.7
6.8
44
171
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
3.6
6.8
29
85
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
5.7
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
119
107
14.15
117.63
3.7
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
70
31
25.96
97.78
3.8
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
329
1275
5.35
77.51
2.9
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
127
283
5.62
56.29
2.8
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
346
1971
3.28
36.01
4.0
2.0
—
—
—
0
0
(4035726)
93
377
2.79
16.12
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
92
409
2.52
13.12
4.0
3.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
15
8.86
10.27
3.8
2.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
114
623
2.06
9.77
2.0
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
85
425
2.20
9.13
1.8
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
99
532
2.06
8.82
3.8
3.9
%
32.3
33.1
0.29
59
354
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
69
327
2.28
8.41
1.6
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
117
679
1.93
8.35
2.2
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
401
3371
1.84
7.72
5.7
4.0
mm/h
11.7
11.2
0.46
373
3126
(3037522) Nuclear Ab [Titer] in Serum
118
705
1.87
7.66
1.5
1.3
titre
687.3
542.6
0.37
33
154
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
70
3.55
7.20
2.2
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
32
4.80
6.73
1.3
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
287
2274
1.59
6.19
9.5
5.5
e9/l
2.0
2.0
0.09
272
2027
(3001604) Monocytes [#/volume] in Blood
280
2207
1.59
6.17
9.5
5.5
e9/l
0.5
0.5
0.07
258
1928
(42870588) Differential panel, method unspecified - Blood
196
1422
1.61
6.13
9.3
5.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
54
265
2.16
6.04
1.9
1.7
g/l
1.2
1.4
0.40
49
244
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
39
167
2.44
5.98
3.6
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
290
2315
1.58
5.97
10.0
5.8
e9/l
0.2
0.2
0.01
270
2052
(3044640) Blood type and Crossmatch panel - Blood
188
1361
1.60
5.88
2.5
2.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
12
24
5.10
5.77
1.8
1.7
e6/l
824.3
501.1
1.09
12
19
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
24
5.10
5.77
1.8
1.4
e6/l
876.8
840.4
—
5
8
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
150
1032
1.64
5.76
2.5
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
235
1800
1.56
5.72
6.7
4.9
mmol/l
1.2
1.2
0.32
202
1632
(3006315) Basophils [#/volume] in Blood
278
2221
1.54
5.53
9.6
5.5
e9/l
0.0
0.0
0.22
256
1935
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
35
150
2.43
5.37
4.1
1.5
g/l
0.2
0.2
4.06
35
141
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
36
157
2.39
5.32
4.1
1.5
g/l
1.0
1.2
4.50
36
147
(3020779) Urea [Moles/volume] in Serum or Plasma
50
251
2.10
5.29
11.0
7.0
mmol/l
7.5
7.9
0.21
45
238
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
385
3335
1.60
5.15
10.7
6.8
u/l
75.8
75.7
0.02
362
3118
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
254
2014
1.51
5.08
7.6
5.6
mmol/l
1.2
1.2
0.04
212
1694
(3024561) Albumin [Mass/volume] in Serum or Plasma
218
1674
1.52
5.07
5.6
4.0
g/l
36.8
36.2
0.99
201
1569
(3011412) CD3 cells [#/volume] in Blood
13
32
4.14
4.92
1.7
2.0
e9/l
1.7
1.3
—
8
20
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
80
483
1.78
4.91
6.9
5.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
23
84
2.82
4.84
2.9
4.0
mg/l
33.4
38.8
0.25
23
68
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
23
84
2.82
4.84
2.9
4.0
mg/l
41.2
23.8
0.72
23
66
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
33
4.02
4.74
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
119
810
1.61
4.67
1.6
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
34
3.90
4.56
2.5
2.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
32
143
2.32
4.51
1.6
1.2
u/ml
15.9
2.2
—
7
17
(3017143) Hepatitis C virus Ab [Presence] in Serum
84
528
1.71
4.47
1.6
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
258
2091
1.47
4.42
9.9
5.7
%
8.1
8.1
0.04
241
1951
(3013650) Neutrophils [#/volume] in Blood by Automated count
305
2555
1.47
4.39
13.0
8.6
e9/l
3.7
3.9
1.48
278
2247
(3006504) Eosinophils/100 leukocytes in Blood
257
2084
1.46
4.37
9.5
5.4
%
2.7
2.8
0.07
240
1932
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
20
72
2.85
4.33
13.8
5.7
iu/ml
593.0
164.8
—
7
9
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
32
146
2.27
4.31
1.6
1.2
u/ml
17.3
11.6
—
8
30
(3007164) IgA [Mass/volume] in Serum or Plasma
136
973
1.54
4.27
1.6
1.5
g/l
2.3
2.2
0.22
82
597
(3002030) Lymphocytes/100 leukocytes in Blood
263
2149
1.46
4.26
9.8
5.6
%
30.6
29.4
1.26
244
1996
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
181
2.12
4.21
1.4
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
260
2126
1.45
4.16
9.5
5.3
%
55.2
56.6
1.16
242
1989
(3004616) Nuclear Ab [Presence] in Serum
19
68
2.86
4.16
2.0
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
135
970
1.53
4.14
5.1
3.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
170
1285
1.48
4.08
3.0
2.3
u/l
56.4
55.7
0.11
160
1184
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
92
608
1.62
4.04
3.2
2.4
e6/l
1.0
1.2
0.28
55
325
(3022096) Basophils/100 leukocytes in Blood
247
2010
1.44
4.01
9.8
5.5
%
0.7
0.7
0.39
231
1860
(4034850)
27
119
2.34
3.94
6.5
6.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
11
7.37
3.87
2.0
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
70
436
1.70
3.85
8.0
4.2
mmol/l
1.0
1.0
0.09
63
398
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
29
3.85
3.82
2.5
1.6
g/l
1.0
1.0
0.33
11
29
(3007853) Bacteria identified in Skin by Aerobe culture
71
446
1.69
3.79
1.6
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
5
12.12
3.77
4.2
2.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
26
116
2.31
3.70
3.1
2.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
163
2.09
3.69
2.2
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
21
87
2.47
3.51
1.5
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
91
620
1.57
3.51
2.5
2.2
ug/g
88.4
110.8
0.59
67
476
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
69
442
1.65
3.42
4.8
2.3
umol/l
5.4
6.0
0.26
61
379
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
59
2.77
3.35
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
241
1998
1.39
3.31
2.7
2.3
nmol/l
78.4
77.3
0.24
210
1819
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
60
2.72
3.25
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
60
2.72
3.25
1.3
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
18
72
2.55
3.24
1.7
1.3
u/ml
126.6
121.3
—
5
17
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
151
2.05
3.22
2.0
1.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
15
5.40
3.20
1.4
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
15
5.40
3.20
1.4
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
83
566
1.56
3.19
3.4
2.5
e6/l
4.2
4.8
0.20
45
285
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
454
4224
1.61
3.18
11.8
10.3
ml/min/173m2
84.9
85.5
0.24
375
3407
(3031040) Bacteria [#/volume] in Urine by Automated count
332
2919
1.38
3.09
5.7
4.2
—
1309.1
—
0
42
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
62
2.63
3.07
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
62
2.63
3.07
1.3
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
62
2.63
3.07
1.3
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
41
234
1.82
3.07
4.3
2.6
e9/l
76.5
72.7
0.32
32
176
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
16
5.06
3.06
1.4
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
16
5.06
3.06
1.0
1.9
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
16
5.06
3.06
1.4
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
16
5.06
3.06
1.0
1.9
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
12
5.90
3.03
3.1
2.4
ug/l
43.3
56.3
—
7
12
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
19
81
2.40
3.02
1.6
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
17
69
2.51
2.99
1.3
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
256
2169
1.36
2.97
8.8
5.5
umol/l
9.4
9.5
0.17
247
2051
(3037467) Urinalysis macro (dipstick) panel - Urine
344
3056
1.38
2.92
6.3
4.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
130
988
1.42
2.91
1.9
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
102
2.21
2.91
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
64
2.55
2.90
3.6
4.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
270
2316
1.35
2.84
4.8
3.9
mmol/l
6.4
6.4
0.01
245
2127
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
133
1024
1.40
2.76
2.5
2.1
mg/l
2.7
2.9
0.43
106
878
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
200
1647
1.35
2.73
1.9
1.9
pmol/l
100.3
98.7
0.18
94
814
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
248
2111
1.34
2.70
4.0
3.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
459
4315
1.57
2.68
4.5
4.1
mmol/l
5.7
5.7
0.90
406
3986
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
24
120
2.05
2.65
1.5
1.2
u/ml
44.3
27.5
—
7
11
(36304419) Bacteria [Presence] in Urine
135
1049
1.39
2.64
4.1
2.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
49
309
1.65
2.61
4.7
3.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
134
1042
1.39
2.61
4.0
2.7
e6/l
0.3
0.4
0.66
102
768
(4062490)
11
38
2.94
2.59
1.4
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
7
7.20
2.55
2.0
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
52
339
1.59
2.44
1.5
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
8
6.30
2.37
2.0
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
44
278
1.64
2.35
1.8
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
21
390
0.52
2.33
3.4
3.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
13
53
2.49
2.29
1.5
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
58
394
1.53
2.29
1.3
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
11
41
2.72
2.29
1.8
1.7
mg/l
24.4
16.8
—
5
10
(3016244) Insulin [Units/volume] in Serum or Plasma
9
29
3.14
2.23
3.7
3.8
mu/l
30.2
15.5
—
9
29
(3012095) Magnesium [Moles/volume] in Serum or Plasma
82
602
1.43
2.21
4.6
2.8
mmol/l
0.8
0.8
0.08
73
564
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
143
1152
1.33
2.19
1.3
1.2
u/ml
0.6
2.0
1.91
32
310
(3004588) Protein electrophoresis panel - Serum or Plasma
38
237
1.65
2.14
1.5
2.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
25
3.23
2.10
1.5
2.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
75
547
1.43
2.10
2.8
2.1
g/l
2.4
2.4
0.33
68
507
(3010813) Leukocytes [#/volume] in Blood
510
4994
2.57
2.07
23.5
17.4
e9/l
6.7
6.5
0.23
497
4865
(3000963) Hemoglobin [Mass/volume] in Blood
510
4994
2.57
2.07
23.6
17.4
g/l
132.1
132.9
0.88
503
4929
(3035941) MCH [Entitic mass]
510
4993
2.58
2.07
23.4
17.2
pg
30.3
30.1
1.84
503
4926
(3026361) Erythrocytes [#/volume] in Blood
510
4993
2.58
2.07
23.5
17.3
e12/l
4.4
4.4
1.66
498
4869
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
20
3.53
2.06
1.4
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
176
1471
1.30
2.06
5.4
2.9
u/l
29.5
28.1
0.42
170
1407
(3007461) Platelets [#/volume] in Blood
510
4991
2.61
2.06
23.5
17.3
e9/l
271.1
265.3
1.18
498
4881
(3024731) MCV [Entitic volume]
510
4991
2.61
2.06
23.4
17.3
fl
91.1
90.7
1.11
503
4925
(3000850) Epithelial cells [#/volume] in Urine
104
806
1.36
2.05
3.4
2.4
e6/l
7.0
8.8
0.31
94
711
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
50
2.43
2.04
1.8
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
50
338
1.53
2.03
4.7
2.6
%
2.1
1.8
0.83
43
298
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
83
2.08
2.03
1.6
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
170
1417
1.30
2.02
3.1
3.0
ng/l
19.2
26.0
0.38
98
826
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
492
4749
1.74
2.01
14.1
9.4
u/l
24.2
23.7
0.26
475
4595
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
69
500
1.44
2.00
3.0
2.2
%
22.8
23.1
0.07
61
424
(3014576) Chloride [Moles/volume] in Serum or Plasma
54
373
1.50
1.99
5.5
6.0
mmol/l
104.1
104.3
0.06
54
362
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
77
570
1.41
1.99
1.9
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
336
3055
1.29
1.98
3.9
2.8
u/l
38.4
39.8
0.16
317
2890
(3002582) Erythrocytes [#/volume] in Urine
140
1141
1.31
1.96
4.3
2.9
e6/l
27.5
57.8
1.00
109
854
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
21
113
1.89
1.94
1.1
1.4
u/l
26.2
25.6
0.02
14
94
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
16
3.78
1.94
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
33
2.76
1.94
2.6
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
170
1425
1.29
1.93
5.1
3.4
e6/l
66.3
66.9
0.01
119
943
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
34
2.68
1.87
1.0
1.1
mg/l
312.7
291.7
—
9
29
(3019550) Sodium [Moles/volume] in Serum or Plasma
470
4499
1.49
1.87
14.8
12.1
mmol/l
139.6
139.7
0.37
449
4363
(3023103) Potassium [Moles/volume] in Serum or Plasma
471
4511
1.50
1.86
15.1
12.2
mmol/l
3.9
3.9
0.08
449
4365
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
49
338
1.50
1.83
4.4
3.5
pmol/l
4.4
4.6
0.85
44
300
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
35
2.60
1.81
1.6
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
137
1127
1.29
1.78
10.0
6.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
54
2.25
1.75
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
18
3.36
1.75
1.3
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
18
3.36
1.75
1.8
2.0
e9/l
0.1
0.2
—
6
18
(3041354) Potassium [Moles/volume] in Venous blood
0
46
0.00
1.71
0.0
2.3
—
3.9
—
0
46
(3035285) Chloride [Moles/volume] in Venous blood
0
46
0.00
1.71
0.0
2.3
—
106.3
—
0
46
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
244
1.56
1.70
1.7
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
113
911
1.31
1.70
1.6
1.5
nmol/l
22.8
22.3
0.12
95
779
(3026782) Osmolality of Urine
94
739
1.33
1.69
3.5
2.4
mosm/kgh2o
494.6
523.1
0.70
83
636
(3025159) Blasts/100 leukocytes in Blood
46
319
1.49
1.69
5.2
4.2
%
0.0
1.3
0.50
18
66
(3017181) Myelocytes/100 leukocytes in Blood
50
353
1.46
1.68
5.1
4.0
%
0.4
0.9
1.59
21
89
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
55
2.21
1.68
3.5
2.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
13
63
2.09
1.61
5.0
2.6
umol/l
27.6
30.8
0.35
13
52
(3022948) Iron [Moles/volume] in Serum or Plasma
77
593
1.35
1.59
3.0
2.1
umol/l
13.0
13.8
0.51
70
549
(3000991) Gas panel - Venous blood
35
232
1.55
1.59
8.1
7.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
29
184
1.61
1.58
1.1
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
47
334
1.45
1.54
5.2
4.1
%
0.0
0.1
1.98
19
81
(1761868) Lipid panel - Serum or Plasma
149
1741
0.80
1.54
2.0
2.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
27
2.61
1.52
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
145
1224
1.26
1.51
2.7
2.0
u/l
93.8
192.9
1.20
138
1159
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
45
0.00
1.50
0.0
2.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
37
2.46
1.48
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
125
1.71
1.46
1.3
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
7
28
2.52
1.45
1.3
1.2
umol/l
12.6
24.7
—
7
28
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
466
4486
1.39
1.45
15.8
11.5
mg/l
19.5
19.6
0.02
375
3432
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
39
2.33
1.43
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
361
3833
0.81
1.42
18.2
14.0
%
13.6
13.6
0.26
352
3758
(3002256) Pathology report gross observation
75
587
1.32
1.40
1.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
45
324
1.43
1.40
4.9
3.9
%
0.1
0.7
1.72
16
62
(4010399)
41
290
1.45
1.39
1.5
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
11
53
2.10
1.39
1.2
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
462
4448
1.36
1.38
4.4
4.1
mmol/l
4.9
4.9
0.72
423
4166
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
143
1.64
1.37
1.6
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
17
2.96
1.36
1.0
1.5
nmol/l
130.8
131.6
—
5
17
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
107
883
1.27
1.35
2.7
2.9
ng/l
518.2
918.1
1.90
91
743
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
39
277
1.44
1.31
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
24
2.52
1.30
1.5
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
34
2.37
1.29
1.1
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
65
505
1.33
1.29
1.5
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
27
178
1.55
1.29
1.6
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
25
2.42
1.24
1.2
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
45
2.02
1.24
2.2
1.3
—
—
—
0
0
(4268621)
9
45
2.02
1.24
2.1
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
43
315
1.40
1.23
2.2
2.9
e9/l
4.0
4.1
0.11
35
256
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
28
405
0.67
1.23
2.9
3.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
30
205
1.49
1.23
1.5
1.3
miu/ml
127.0
238.2
1.01
14
105
(3019309) Folate [Moles/volume] in Red Blood Cells
83
672
1.28
1.23
1.6
1.7
nmol/l
1027.7
1205.1
1.15
61
499
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
19
2.65
1.22
2.2
3.2
—
—
—
0
0
(3020891) Body temperature
18
109
1.67
1.20
5.4
4.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
38
274
1.42
1.19
1.7
2.7
g/l
66.4
67.5
0.37
33
249
(40761511) CBC panel - Blood by Automated count
485
4722
1.44
1.19
14.0
10.7
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
26
2.32
1.19
4.3
1.9
%
94.5
104.3
—
6
26
(3045414) Leukocytes [Presence] in Urine
29
199
1.48
1.17
1.6
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
39
2.07
1.15
5.8
2.5
nmol/l
5.9
2.7
—
8
39
(3015377) Calcium [Moles/volume] in Serum or Plasma
167
1469
1.20
1.15
2.7
3.3
mmol/l
2.4
2.4
0.27
139
1305
(3051651) Icteric interference index of Serum or Plasma
5
20
2.51
1.15
2.8
3.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
113
0.44
1.14
1.4
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
143
1.56
1.13
5.3
3.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
31
2.27
1.10
2.1
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
66
1.84
1.09
1.3
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
66
1.84
1.09
1.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
21
2.39
1.09
2.8
4.2
u/ml
5329.0
685.8
—
5
21
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
21
2.39
1.09
1.8
1.4
ug/l
7.9
8.4
—
5
21
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
41
1.97
1.09
1.5
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
2.3
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
2.3
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
2.3
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
215
1945
1.18
1.07
10.6
8.2
e9/l
0.0
0.0
0.15
182
1592
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
21
137
1.56
1.07
6.0
3.0
mmol/l
23.5
24.4
0.64
21
126
(3023368) Bacteria identified in Blood by Culture
105
889
1.23
1.07
4.9
3.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
38
281
1.38
1.05
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
46
1.97
1.04
1.3
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
46
1.97
1.04
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
71
578
1.26
1.02
1.5
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
238
2178
1.17
1.02
4.3
3.4
estimate
0.0
0.0
0.00
30
416
(3026008) Bacteria identified in Urine by Culture
154
1360
1.19
1.01
3.0
2.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
19
123
1.57
1.01
3.6
2.1
%
196.0
168.5
0.86
19
118
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
43
328
1.34
0.99
4.9
3.0
ng/l
97.9
72.3
0.68
38
295
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
457
4429
1.27
0.99
4.4
4.0
mmol/l
1.6
1.6
0.43
411
4132
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
2.1
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
36
1.96
0.97
2.6
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
31
0.00
0.96
0.0
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.0
—
0.3
—
0
10
(3036481) Cortisol [Moles/volume] in Serum or Plasma
54
428
1.29
0.96
2.4
2.1
nmol/l
396.3
370.0
0.50
47
399
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
32
0.00
0.95
0.0
1.0
—
0.4
—
0
8
(3015736) pH of Urine
189
1706
1.17
0.95
4.3
3.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
97
825
1.22
0.95
1.5
1.6
pmol/l
460.7
30186424.3
1.05
84
699
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
86
724
1.23
0.93
2.5
2.6
mmol/l
2.4
2.4
0.81
75
642
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
70
1.73
0.93
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
238
2191
1.16
0.92
5.9
4.7
estimate
0.0
0.0
0.50
35
421
(21494434) Karyotype in Bone marrow
6
28
2.16
0.91
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
29
2.08
0.89
5.0
8.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
63
515
1.25
0.89
1.8
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
30
2.01
0.87
4.0
3.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
30
2.01
0.87
1.3
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
75
628
1.23
0.86
1.3
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
110
957
1.19
0.85
1.3
1.3
u/ml
12.4
12.2
0.01
43
383
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
88
1.61
0.85
2.7
2.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
138
0.57
0.84
1.6
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
113
0.53
0.84
2.5
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
31
232
1.36
0.83
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
65
1.71
0.83
1.2
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
131
1162
1.17
0.81
3.4
3.0
mmol/l
6.4
7.0
1.07
113
982
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
24
326
0.72
0.80
4.2
3.5
mmol/l
1.2
1.2
0.20
24
281
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
30
393
0.75
0.79
1.4
1.3
iu/l
40.0
28.7
0.73
22
337
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
33
1.83
0.79
1.2
1.0
—
—
—
0
0
(4306422)
11
66
1.68
0.79
1.3
1.1
—
—
—
0
0
(44790047)
8
48
1.68
0.79
1.4
1.5
—
—
—
0
0
(44790049)
8
48
1.68
0.79
1.4
1.5
—
—
—
0
0
(44790048)
8
48
1.68
0.79
1.4
1.5
—
—
—
0
0
(44806118)
8
48
1.68
0.79
1.4
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
238
2210
1.14
0.79
4.4
3.4
estimate
0.0
0.0
0.80
35
412
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
463
4515
1.24
0.78
4.7
4.5
mmol/l
2.9
2.9
0.43
415
4199
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3013512) EKG study
128
1137
1.17
0.78
3.6
3.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
119
1054
1.17
0.75
1.8
1.7
mg/l
1.0
0.9
0.16
80
804
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
58
692
0.82
0.73
2.6
3.3
ng/l
95.1
293.6
0.99
37
442
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
109
0.55
0.73
1.2
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
57
1.59
0.71
1.9
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
26
1.93
0.71
3.2
1.5
ug/l
30.0
27.0
—
5
26
(44813793)
7
41
1.72
0.70
1.1
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
112
1256
0.86
0.70
3.0
3.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
116
1033
1.16
0.69
4.1
2.3
umol/l
309.6
5167.0
3.88
102
906
(3037756) Immunofixation for Serum or Plasma
11
69
1.61
0.69
1.3
1.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
27
1.86
0.68
1.2
1.7
promille
1.4
1.1
—
5
19
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
438
4262
1.18
0.67
4.0
3.6
mmol/l
1.2
1.2
0.03
387
3958
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
216
1.31
0.65
1.5
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
118
1058
1.15
0.64
3.6
3.1
mg/l
75.3
318.4
1.07
61
626
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
395
3821
1.14
0.63
4.7
4.4
pmol/l
14.6
14.5
0.55
364
3542
(4027681)
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
20
0.00
0.60
0.0
1.1
—
46267.1
—
0
7
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
0
21
0.00
0.60
0.0
1.0
—
1342.2
—
0
10
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.1
—
0.3
—
0
15
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
415
4032
1.15
0.60
5.1
4.9
mmol/mol
37.8
38.5
1.39
374
3764
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
72
1.54
0.59
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
140
1.37
0.59
1.5
1.4
ug/g
343.2
315.6
0.22
13
80
(3003181) Sodium [Moles/volume] in Urine
8
53
1.52
0.58
1.3
1.3
mmol/l
44.8
67.7
—
8
46
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
23
0.00
0.58
0.0
1.1
—
121.4
—
0
16
(40768806) Pleura Pathology biopsy report
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
108
971
1.14
0.57
1.5
1.3
iu/ml
19.6
28.8
1.03
30
315
(1761482) Bacteria [#/volume] in Urine by Culture
5
88
0.56
0.56
1.6
4.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
160
0.68
0.56
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
160
0.68
0.56
1.4
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
45
377
1.21
0.55
1.8
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
195
1.30
0.55
4.7
2.9
mmol/l
1.5
1.9
0.24
20
147
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
38
1.59
0.54
1.5
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
66
1.53
0.53
1.5
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
34
278
1.24
0.53
5.5
3.0
kpa
5.7
5.9
0.62
34
273
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
61
529
1.17
0.52
2.1
1.5
%
1.2
1.3
1.38
52
472
(3045424) Erythrocytes [Presence] in Urine
12
83
1.46
0.52
1.3
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
197
1.28
0.52
2.9
2.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
353
1.21
0.51
2.6
2.1
ml/min/173m2
71.0
74.5
0.20
14
136
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.50
2.0
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
93
1.41
0.48
1.8
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
46
1.53
0.48
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
104
945
1.13
0.48
5.7
3.6
kg/l
1.0
1.0
—
6
138
(3049717) Cytology report of Urine Cyto stain
14
102
1.38
0.47
1.7
2.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
47
1.50
0.47
3.1
1.9
%
69.0
58.7
—
7
47
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
146
1.31
0.47
1.2
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
331
0.81
0.47
1.2
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
44
375
1.19
0.47
1.7
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
18
232
0.77
0.47
1.3
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
81
0.61
0.46
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
147
1.30
0.46
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
46
532
0.85
0.45
1.4
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
130
1.32
0.44
2.4
3.0
g/l
0.6
0.2
—
7
39
(3001122) Ferritin [Mass/volume] in Serum or Plasma
232
2207
1.09
0.44
3.4
2.8
ug/l
89.1
75.8
0.77
213
2067
(42529406) Shigella sp [Presence] in Stool by Culture
19
148
1.29
0.44
1.2
1.2
—
—
—
0
0
(3012544) pH of Venous blood
34
285
1.21
0.44
5.4
3.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
196
0.76
0.43
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
196
0.76
0.43
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
196
0.76
0.43
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
196
0.76
0.43
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
295
1.20
0.43
1.9
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
16
206
0.77
0.42
1.3
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
58
1.39
0.41
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
115
1061
1.11
0.41
1.6
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
15
0.00
0.41
0.0
6.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
8
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
59
1.36
0.41
1.3
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
132
1.30
0.41
1.2
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
32
269
1.20
0.40
6.7
5.9
mmol/l
1.3
1.2
0.14
32
258
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
18
0.00
0.40
0.0
1.4
—
9.2
—
0
5
(3045788) Cell count panel - Pleural fluid
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
80
1.38
0.38
1.1
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
119
1106
1.10
0.37
4.0
3.8
mg/mmol
12.6
8.2
0.38
63
643
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
69
1.31
0.37
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
338
3284
1.08
0.37
3.3
3.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
70
1.29
0.37
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
71
1.27
0.36
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
76
0.65
0.36
1.0
1.8
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
18
144
1.26
0.35
4.5
2.1
%
1.0
1.1
0.24
18
144
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
6
47
1.28
0.32
1.2
1.3
pmol/l
223.0
415.5
—
6
35
(3000492) Spirometry study
38
431
0.87
0.31
1.7
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
164
0.79
0.31
1.3
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
130
1225
1.08
0.31
6.5
3.5
ph
7.4
7.4
0.35
17
238
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
28
240
1.18
0.31
2.4
2.2
ug/l
5.5
5.5
0.01
21
211
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
75
1.34
0.30
1.3
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
163
0.79
0.30
1.2
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
108
0.74
0.29
1.3
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
15
184
0.81
0.29
3.3
5.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
184
0.81
0.29
1.9
3.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
150
1426
1.07
0.28
5.7
6.8
inr
1.1
1.1
0.11
30
453
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
140
1.22
0.28
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
182
0.82
0.26
1.5
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
141
1.21
0.26
1.2
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
38
339
1.13
0.26
1.3
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
113
1194
0.93
0.25
1.8
1.7
mmol/l
1.3
1.4
0.39
103
1028
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
159
0.81
0.25
8.3
9.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
57
524
1.10
0.24
2.7
1.8
s
28.7
29.5
0.56
57
507
(3044927) Protein electrophoresis panel - Urine
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
61
565
1.09
0.22
1.9
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
79
1.27
0.22
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
10
0.00
0.21
0.0
2.3
—
1.2
—
0
10
(3035880) pH of Pleural fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(4094501)
8
105
0.76
0.21
1.1
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
14
0.00
0.20
0.0
3.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
27
242
1.12
0.18
1.1
1.1
—
258.6
—
0
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
142
0.84
0.17
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
62
1.13
0.17
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
129
1.17
0.17
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
63
1.11
0.17
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
423
4186
1.06
0.17
15.6
12.3
%
39.6
39.5
0.12
323
3221
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
68
1.18
0.16
1.9
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
68
1.18
0.16
2.9
2.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
8
68
1.18
0.16
1.3
1.1
%
117.3
120.6
—
8
61
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
36
390
0.92
0.16
4.0
3.9
ug/l
3.4
8.5
1.86
29
317
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
72
1.11
0.16
1.9
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
72
1.11
0.16
1.9
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
81
1.11
0.15
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
93
1.19
0.14
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
93
1.19
0.14
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
19
211
0.90
0.13
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
261
0.92
0.12
2.2
2.1
u/l
238.5
3873.0
—
7
111
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
124
1.13
0.11
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
96
1.15
0.10
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
119
1159
1.03
0.10
5.5
3.7
estimate
0.0
0.0
0.80
34
425
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
197
0.91
0.10
1.7
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
37
391
0.94
0.09
1.7
1.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
174
1708
1.03
0.09
4.6
3.5
—
—
—
0
0
(3044889) 12 lead EKG panel
298
2947
1.03
0.09
3.6
3.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
32
339
0.94
0.09
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
58
558
1.04
0.08
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
127
1298
0.97
0.08
1.4
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
113
0.88
0.08
1.1
1.2
mmol/l
3.2
3.7
—
10
102
(4281824)
5
62
0.80
0.08
1.4
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
66
1.06
0.08
1.4
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
85
0.82
0.07
3.1
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
8
91
0.88
0.07
4.5
4.6
mmol/l
3.6
3.8
—
8
81
(3027008) Opiates [Presence] in Urine
16
173
0.92
0.07
1.3
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
92
0.87
0.07
2.9
3.4
e9/l
4.1
4.4
—
8
92
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
93
0.86
0.06
3.4
3.8
%
60.1
58.6
—
8
93
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
46
477
0.96
0.06
1.7
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
152
0.92
0.06
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
172
0.93
0.06
1.1
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
436
4342
1.03
0.05
5.6
5.2
mu/l
1.8
2.1
0.58
398
4049
(3016879) Cocaine [Presence] in Urine
15
161
0.93
0.05
1.3
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
120
1.09
0.05
1.4
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
150
0.93
0.04
2.4
2.0
iu/l
3.0
5.6
—
7
56
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
92
1.09
0.03
2.0
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
14
132
1.06
0.02
5.1
3.2
%
44.0
49.6
0.44
14
132
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
44
448
0.98
0.01
1.2
1.2
iu/ml
105.3
150.5
0.57
15
197
(40760892) CBC W Ordered Manual Differential panel - Blood
110
1091
1.01
0.01
7.3
4.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
276
0.98
0.00
2.3
2.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
35
344
1.02
0.00
5.1
7.2
mmol/l
0.8
1.5
0.58
23
275
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
96
1.04
0.00
2.0
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
174
0.98
0.00
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
174
0.98
0.00
1.3
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
174
0.98
0.00
1.7
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
187
1.02
0.00
1.3
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
564
0.99
0.00
2.1
1.9
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3032773) Endomysium IgG Ab [Titer] in Serum
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
1.1
nmol/l
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
5
52
0.96
0.00
1.4
1.8
mmol/l
7.2
7.1
—
5
30
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
2.4
—
1.2
—
0
8
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
80
1.00
0.00
3.0
2.1
%
13.1
13.2
—
8
80
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
1.7
—
573.8
—
0
6
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
29.7
—
0
5
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
33.9
—
0
6
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_VAGINAL_LSIL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_VAGINAL_LSIL | 1.229 [1.05, 1.44] | 0.012 |
| Birth year | 1.0 [0.99, 1.01] | 0.998 |
During the follow-up period (1.1.1998 — 31.12.2019), 199 out of 2071 females with N14_VAGINAL_LSIL died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have N14_VAGINAL_LSIL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.104% | No data |
| 5 | 0.814% | No data |
| 10 | 2.011% | No data |
| 15 | 4.023% | No data |
| 20 | 7.318% | No data |
Relationships between endpoints
↥Index endpoint: N14_VAGINAL_LSIL – LSIL lesion of the vagina
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data